In the last trading session, 1.81 million Sage Therapeutics Inc (NASDAQ:SAGE) shares changed hands as the company’s beta touched 0.88. With the company’s per share price at $12.58 changed hands at -$3.05 or -19.51% during last session, the market valuation stood at $756.18M. SAGE’s last price was a discount, traded about -376.87% off its 52-week high of $59.99. The share price had its 52-week low at $15.06, which suggests the last value was -19.71% down since then. When we look at Sage Therapeutics Inc’s average trading volume, we note the 10-day average is N/A shares, with the 3-month average coming to 918.45K.

Sage Therapeutics Inc (NASDAQ:SAGE) trade information

Instantly SAGE was in red as seen at the end of in last trading. With action -23.53%, the performance over the past five days has been red. The drop to weekly highs of 16.81 on N/A, N/A subtracted -19.51% to the stock’s daily price. The company’s shares are showing year-to-date downside of -41.95%, with the 5-day performance at -23.53% in the red. However, in the 30-day time frame, Sage Therapeutics Inc (NASDAQ:SAGE) is -35.05% down. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.

Sage Therapeutics Inc (SAGE) estimates and forecasts

Data shows that the Sage Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -35.62% over the past 6 months, a 33.04% in annual growth rate that is considerably higher than the industry average of 9.70%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -2.28%. The 2024 estimates are for Sage Therapeutics Inc earnings to increase by 31.07%, but the outlook for the next 5-year period is at 16.80% per year.